Vascular hemichorea/hemiballismus and topiramate.
Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Vascular Hemichorea/Hemiballismus and Topiramate.”. Movement Disorders.
Search
Search results
374 results found
Long-term evaluation of deep brain stimulation of the thalamus.
Pahwa, R, KE Lyons, SB Wilkinson, RK Simpson Jr, WG Ondo, RA Hauser, and . 2006. “Long-Term Evaluation of Deep Brain Stimulation of the Thalamus.”. J Neurosurg.
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson’s disease. Movement Disorders 2005;20:1205-1209.
Zesiewicz, TA, KL Sullivan, JL Maldonado, and RA Hauser. 2005. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Movement Disorders 2005;20:1205-1209.”. Movement Disorders.
Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.
Adler, CH, RA Hauser, K Sethi, JN Caviness, L Marlor, M Anderson, and JG Hentz. 2004. “Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.”. Neurology.
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 2003;113:154-161.
Crawford, FC, G Ait-Ghezala, M Morris, MJ Sutcliffe, RA Hauser, AA Silver, and MJ Mullan. 2003. “Translocation Breakpoint in Two Unrelated Tourette Syndrome Cases, Within a Region Previously Linked to the Disorder. Hum Genet 2003;113:154-161.”. Hum Genet.
Clozapine withdrawal symptoms in a Parkinson’s disease patient. Movement Disorders 2002;17:1365-1367.
Zesiewicz, TA, S Borra, and RA Hauser. 2002. “Clozapine Withdrawal Symptoms in a Parkinson’s Disease Patient. Movement Disorders 2002;17:1365-1367.”. Movement Disorders.
The long-term safety and efficacy of pramipexole in advanced Parkinson’s disease. Parkinsonism and Related Disorders 2001;7(2)115-120.
Weiner, WJ, SA Factor, J Jankovic, RA Hauser, JW Tetrud, CH Waters, LM Shulman, and . 2001. “The Long-Term Safety and Efficacy of Pramipexole in Advanced Parkinson’s Disease. Parkinsonism and Related Disorders 2001;7(2)115-120.”. Parkinsonism and Related Disorders.
Adult Chediak-Higashi parkinsonian syndrome with dystonia. Movement Disorders 2000;15:705-708.
Hauser, RA, J Friedlander, MJ Baker, J Thomas, and R Zuckerman. 2000. “Adult Chediak-Higashi Parkinsonian Syndrome With Dystonia. Movement Disorders 2000;15:705-708.”. Movement Disorders.
Transplantation of human fetal striatal tissue in Huntington's disease: rationale for clinical studies. Novartis Foundation Symposium 2000;231:129-138; discussion 139-147.
Freeman, TB, RA Hauser, AE Willing, T Zigova, PR Sanberg, and S Saporta. 2000. “Transplantation of Human Fetal Striatal Tissue in Huntington’s Disease: Rationale for Clinical Studies. Novartis Foundation Symposium 2000;231:129-138; Discussion 139-147.”. Novartis Foundation Symposium.
Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.
Zesiewicz, TA, and RA Hauser. 2000. “Depression in Parkinson’s Disease. CNS Drugs 2000;17;593-600.”. CNS Drugs.